ArticleMolecular neurobiology2025
Reduced Availability of Essential Amino Acids Disrupts Differentiation of Anorexigenic POMC Neurons in the Fetal Rat Hypothalamus.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intrauterine growth restriction (IUGR) is associated with an elevated risk of long-term metabolic disorders, including obesity and type 2 diabetes, aligning with the Developmental Origins of Health and Disease hypothesis. However, the mechanisms underlying metabolic programming remain elusive. This study investigates the impact of gestational protein restriction (PR) on fetal hypothalamic development, focusing on the formation of neuronal populations regulating appetite and energy balance. Using a rat isocaloric PR model (8% protein preconception, 4% during gestation), we examined hypothalamic development at gestational days 15 and 17-critical stages for cell fate determination and differentiation. We measured maternal, fetal, and placental weights, and maternal plasma amino acid concentrations. Then, we performed single-cell RNA-seq to assess the impact on neuronal differentiation and uncover mechanisms, which were further investigated via EdU-labeling, immunohistochemistry, and RNAscope. Additionally, we assessed mTOR signaling and analyzed methylation patterns in the Pomc gene. Gestational PR reduced maternal concentrations of essential amino acids, impaired fetal growth, and selectively disrupted the differentiation of ISL1-precursors into POMC neurons, while sparing NPY precursor differentiation. This correlated with downregulated differentiation genes and disrupted mTOR signaling, linked to decreased maternal branched-chain amino acids and altered expression of the amino acid transporter Lat1. Epigenetic alterations in the Pomc promoter but not its enhancers may contribute to the phenotype. Adequate protein intake is crucial for POMC differentiation in the fetal arcuate nucleus. Further studies should investigate additional developmental windows to optimize dietary recommendations for at-risk pregnancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.